Search
gender-affirming hormone therapy
Epidemiology:
- primary medical intervention sought by transgender persons
Indications:
- well-documented gender dysphoria
Adverse effects:
- limits fertility
- discussion of fertility preservation options prior to initiation of gender-affirming hormone therapy [1]
Management:
- gender incongruence whose sex recorded as female at birth
- testosterone, including testosterone gel
Related
transgender person
General
hormonal therapy
References
- Medical Knowledge Self Assessment Program (MKSAP) 18,
American College of Physicians, Philadelphia 2018
- Hembree WC, Cohen-Kettenis PT, Gooren L et al
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons:
An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903.
PMID: 28945902
- Safer JD, Tangpricha V.
Care of Transgender Persons.
N Engl J Med. 2019 Dec 19;381(25):2451-2460.
PMID: 31851801 Review. No abstract available.
https://www.nejm.org/doi/pdf/10.1056/NEJMcp1903650
- NEJM Knowledge+ Endocrinology